VBI Vaccines Inc. (Nasdaq: VBIV) (“VBI”), a commercial-stage biopharmaceutical company developing next-generation infectious disease and immuno-oncology vaccines, today announced that the company will participate in the Oppenheimer Boston Oncology Insight Summit July 10 – 11, 2018. The two-day summit will feature a series of discussions with primary investigators at the Whitehead Institute in Cambridge, Massachusetts, followed by one-on-one meetings with institutional investors at the Four Seasons Hotel in Boston, MA.

Event Details